DelNova is developing proprietary therapies by leveraging advances in drug delivery technology. They have identified an anticholinesterase class of drugs as a means of accelerating muscle recovery by indirectly increasing the neurotransmitter deficit caused by botulinum toxin.

Biotechnology

Delivery

Health Care

Staffing & Recruiting

Delnova

Delnova's headquarters in Illinois City, IL, United States

Mary Gardner

Hannah Roddy

Dimas Jiménez

Steven Yoelin

Sameer B. Shah

Edward A. Ogunro

Daniel M. Bradbury

Pradeep Tyagi

Kurt C. Gunter

Patricia S. Walker

Randall D. Ostroff

Michael B. Chancellor

Description

People

Jobs